Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
D+B Rechtsanwälte is a German law firm positioned as a “law firm for the healthcare industry,” focusing on medical law and legal services for the healthcare sector. According to the main text, its team has more than 30 members and serves clients including physicians, pharmacists, pharmaceutical and medical device manufacturers, medical professional associations, medical aid providers, hospitals, parliamentary bodies, psychotherapists, and associations. It can also provide advisory services at both the German domestic and international levels.
Based on the capabilities listed on the website, D+B covers a wide range of legal issues across the healthcare value chain, including Praxis & MVZ, inpatient care, pharmacies, pharmaceuticals, medical devices, medical aids, digital health, health data protection, Healthcare-Compliance, criminal law, startups, M&A Health Care/Life Sciences, public and government affairs, and tendering procedures. Its focus is not software functionality, but specialized legal consulting and regulatory support for the healthcare industry.
The main text does not disclose its fee model, quotation process, service packages, or standardized delivery workflow, nor does it mention free consultations, trials, or online purchasing. As a result, its cost structure, project timelines, and service boundaries cannot be assessed. For enterprise clients, it would typically be necessary to contact the firm by phone or email for further confirmation, though this is not explicitly described in the main text as part of its business model.
Its strengths lie in its vertical focus on the healthcare industry, covering highly specialized areas such as compliance, data protection, digital health, pharmaceuticals, medical devices, M&A, and government affairs. The main text also mentions recognition from the JUVE Handbook 2024/25 and WirtschaftsWoche “TOP Kanzlei 2026,” giving it a degree of industry endorsement. The drawback is that it is not a SaaS or enterprise software product, and therefore lacks productized features, third-party integrations, permission management, APIs, cloud deployment, self-hosting, and other criteria typically used to evaluate enterprise software. Its information transparency is also mainly limited to descriptions of its practice areas.
It is suitable for organizations operating in the healthcare sector in Germany or Europe, such as healthcare providers, pharmaceutical and medical device companies, digital health startups, hospitals, industry associations, and organizations that need to handle health data protection, medical compliance, regulatory communication, or M&A matters.
The main text does not provide information about access from mainland China, Chinese-language services, or cross-border accessibility, so actual availability is unknown.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on db-law.de official site.
db-law.de is an Germany Legal & Tax provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach db-law.de directly.